Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Tolerability of NNC0141-0000-0100 in Subjects With Rheumatoid Arthritis
This study is ongoing, but not recruiting participants.
Study NCT01370902   Information provided by Novo Nordisk

First Received on May 31, 2011.   Last Updated on May 8, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Inflammation
Rheumatoid Arthritis
Additional conditions recognized in this trial
Arthritis
Arthritis, Rheumatoid
More general conditions related to this trial
Autoimmune Diseases
Connective Tissue Diseases
Immune System Diseases
Joint Diseases
Musculoskeletal Diseases
Pathologic Processes
Rheumatic Diseases
Interventions listed in this trial
NNC 0141-0000-0100
placebo
Sponsors listed in this trial
Novo Nordisk


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services